1. Home
  2. WEYS vs NMRA Comparison

WEYS vs NMRA Comparison

Compare WEYS & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEYS
  • NMRA
  • Stock Information
  • Founded
  • WEYS 1906
  • NMRA 2019
  • Country
  • WEYS United States
  • NMRA United States
  • Employees
  • WEYS N/A
  • NMRA N/A
  • Industry
  • WEYS Apparel
  • NMRA
  • Sector
  • WEYS Consumer Staples
  • NMRA
  • Exchange
  • WEYS Nasdaq
  • NMRA Nasdaq
  • Market Cap
  • WEYS 341.7M
  • NMRA 287.6M
  • IPO Year
  • WEYS N/A
  • NMRA 2023
  • Fundamental
  • Price
  • WEYS $33.21
  • NMRA $0.69
  • Analyst Decision
  • WEYS
  • NMRA Buy
  • Analyst Count
  • WEYS 0
  • NMRA 8
  • Target Price
  • WEYS N/A
  • NMRA $9.29
  • AVG Volume (30 Days)
  • WEYS 22.6K
  • NMRA 919.9K
  • Earning Date
  • WEYS 05-06-2025
  • NMRA 05-12-2025
  • Dividend Yield
  • WEYS 9.20%
  • NMRA N/A
  • EPS Growth
  • WEYS N/A
  • NMRA N/A
  • EPS
  • WEYS 3.04
  • NMRA N/A
  • Revenue
  • WEYS $286,762,000.00
  • NMRA N/A
  • Revenue This Year
  • WEYS N/A
  • NMRA N/A
  • Revenue Next Year
  • WEYS N/A
  • NMRA N/A
  • P/E Ratio
  • WEYS $10.73
  • NMRA N/A
  • Revenue Growth
  • WEYS N/A
  • NMRA N/A
  • 52 Week Low
  • WEYS $25.51
  • NMRA $0.62
  • 52 Week High
  • WEYS $41.05
  • NMRA $17.19
  • Technical
  • Relative Strength Index (RSI)
  • WEYS 66.76
  • NMRA 36.84
  • Support Level
  • WEYS $30.07
  • NMRA $0.63
  • Resistance Level
  • WEYS $32.25
  • NMRA $0.72
  • Average True Range (ATR)
  • WEYS 1.50
  • NMRA 0.06
  • MACD
  • WEYS 0.52
  • NMRA 0.02
  • Stochastic Oscillator
  • WEYS 88.42
  • NMRA 35.71

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale and the North American retail segment. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

Share on Social Networks: